Search
Cosmos Health Inc
COSMAdd to Watchlist
0.237USD
+0.035+17.61%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
9.74MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+17.61%
5 Days
+37.69%
1 Month
-12.48%
6 Months
-53.96%
Year to Date
-52.39%
1 Year
-44.08%
Key Figures
0.203Open
0.246High
18.87MVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
45.94%Turnover Ratio
0.202Prev. Close
0.201Low
2.74MTurnover
LossP/E Static
0.49P/B
0.00%Div Yield TTM
-35.35%ROA
1.32052wk High
1.78Volume Ratio
-22.38MNet Profit
41.07MShares
-0.6602EPS TTM
4.17Beta
-92.33%ROE
0.24652wk Low
22.42%Amplitude
5.76%Gross Margin
9.74MMarket Cap
-3.59Reward/Risk
7.13%Risk Rate
TradingKey Stock Score of Cosmos Health Inc
Currency: USD Updated: 2026-07-02Key Insights
Cosmos Health Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 123 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 4.50.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cosmos Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
Cosmos Health Inc Highlights
StrengthsRisks
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.28% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.27M.
Fairly Valued
The company’s latest PE is -0.36, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.44M shares, decreasing 55.80% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 10.49.
Analyst Rating
Based on
0
analysts
--
Current Rating
4.500
Target Price
+2132.14%
Upside Space
Cosmos Health Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cosmos Health Inc Info
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Ticker SymbolCOSM
CompanyCosmos Health Inc
CEOSiokas (Grigorios)
Websitehttps://www.cosmosholdingsinc.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Cosmos Health Inc (COSM)?
The current price of Cosmos Health Inc (COSM) is 0.24.
What is the symbol of Cosmos Health Inc?
The ticker symbol of Cosmos Health Inc is COSM.
What is the 52-week high of Cosmos Health Inc?
The 52-week high of Cosmos Health Inc is 1.32.
What is the 52-week low of Cosmos Health Inc?
The 52-week low of Cosmos Health Inc is 0.25.
What is the market capitalization of Cosmos Health Inc?
The market capitalization of Cosmos Health Inc is 9.74M.
What is the Earnings Per Share (EPS TTM) of Cosmos Health Inc (COSM)?
The Earnings Per Share (EPS TTM) of Cosmos Health Inc (COSM) is -0.63.